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Sanita` Elettronica e Telemedicina (ONSET)Objectives To review information on cardiovascular health
and migration, to stress the attention of researchers that
much needs to be done in the collection of sound data in
Italy and to allow policy-makers to identify this issue as an
important public health concern.
Background In Italy, the rate of immigrants in the total
number of residents increased from 2.5% in 1990 to 7.4% in
2010, and currently exceeds 10% in regions such as
Lombardia, Emilia Romagna and Toscana.
Methods A consensus statement was developed by
approaching relevant Italian national scientific societies
involved in cardiovascular prevention. Task force
members were identified by the president and/or the
boards of each relevant scientific society or working group,
as appropriate. To obtain a widespread consensus, drafts
were merged and distributed to the scientific societies for
local evaluation and revision by as many experts as
possible. The ensuing final draft was finally approved by
scientific societies.
Results In several western European countries, the
prevalence of hypertension, diabetes, chronic kidney
disease, obesity and metabolic syndrome was found to be
higher among immigrants than in the native population.
Although migrants are often initially healthier than non-
migrant populations in their host countries, genetic factors,
and changing environments with lifestyle changes, social
exclusion and insufficient medical control may expose them
to health challenges. Cultural reasons may also hamperopyright © Italian Federation of Cardiology. Una
1558-2027  2014 Italian Federation of Cardiologyboth the dissemination of prevention strategies andmigrant
communication with healthcare providers. However, great
diversity exists across and within different groups of
migrants, making generalizations very difficult and many
countries do not collect registry or survey data for migrant’s
health.
Conclusions In the present economic context, the
European Union is placing great attention to improve
data collection for migrant health and to support
the implementation of specific prevention policies
aimed at limiting the future burden of cardiovascular
and renal disease, and the consequent load for health
systems. Wider initiatives on the topic are awaited
in Italy.
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Europe, a source of emigrants in the 19th century and first
half of the 20th century, is now a net recipient of
migrants.1 In 2010 there were 47.3 million foreign-born
residents in Europe, corresponding to 9.4% of the total
population (Fig. 1).2 Germany, France and the United
Kingdom are the Member States of Europe with the
highest numbers of immigrants.3 However, the migrant
influx to these countries from 2001 has become relatively
modest compared with Spain and Italy where the per-
centage of international migrants as a percentage of the
population increased from 2.1 and 2.5% in 1990 to 14.1%
and 7.4% in 2010, respectively.3
In Italy, migrants are an expanding global population of
growing social, demographic and political importance.
The rate of immigrants in the total number of residents
currently exceeds 10% in regions such as Lombardia,
Emilia Romagna and Toscana.4 The incidence is higher
amongminors (1 million) and among young adults (18–44
years), with consequent higher visibility at school (over
700 000) and on the labor market (over 2 million). Accord-
ing to ‘The Immigration Statistics Dossier 2011’5 the
foreign workers currently account for one-tenth of total
employment. Foreigners, in fact, have a younger average
age than Italians (32 years against 44 years for the total
population),1 with an incidence of 22.0% of minors (5.1
percentage points higher than the average) and people of
working age of 75.7% (10 percentage points higher),
whereas among the migrants people aged 65 years and
older are only 2.4% (minus 17.9 percentage points).Similar age distribution was recorded in other European
countries. Probably because of the young age of migrants,
the attention of most European member states on
migrant health is mainly focused on emergency care.
Italy is one of the five countries (theNetherlands, France,
Italy, Portugal and Spain) with explicit entitlements for
specific services (e.g. primary care, maternity care),
and/or for specific groups (e.g. children, pregnant women).
In Italy, the pursuit of employment or registration as
unemployed (current employment centres) give to foreign
citizens legally resident (regular immigrants) the right of
compulsory registration to theServizio SanitarioRegionale
(SSR).6 Those regular immigrants residing in Italy for a
period exceeding 3 months (for study, au pairs, religious
personnel), who are not entitled to compulsory regis-
tration, are required to insure against the risk of sickness,
accident andmaternity benefits, by entering into an insur-
ance policy with an Italian or foreign insurance company,
valid on the national territory or, alternatively, they may
request voluntary registration to SSR, against payment of a
contribution.Undocumentedmigrants in Italy are entitled
to receive: emergency care, maternity care until 6 months
postpartum, children’s care and care and prevention of
infectious diseases (including HIV and tuberculosis and
children’s vaccination among others). Undocumented
migrants will be normally requested to pay a user’s fee
unless he/she officially declares to be poor and unable to
pay. In this case, care is provided free of charge. Only four
European Member States (the Netherlands, France, Por-
tugal and Spain) offered undocumentedmigrants access to
the same range of services as nationals of that country as
long as they met certain preconditions, such as proof of
identity or residence.3,7–9
Disparities often exist between a migrant population’s
place of origin and its destination, particularly with
relation to health determinants.10 Migration across health
and disease disparities may influence the epidemiology
of certain diseases globally and in nations receiving
migrants. Traditionally, migration health activities have
been focused on the recognition, identification and man-
agement of communicable diseases such as tuberculosis,
leprosy or syphilis at the time and place of the migrant
arrival.11 These border control practices were designed
for national application through policies of exclusion and
lack an integrated international perspective. Current
dynamics of migration and rates of population mobility
are indeed creating new health challenges for existing
policy.8,12 Non-communicable diseases (in particular
diabetes and hypertension) have sharply increased duringthorized reproduction of this article is prohibited.
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culture of prevention is not yet spread at population
level.13 Lifestyle-associated health issues, including
tobacco use and alcohol consumption, as well as the lack
of implementation of prevention strategies among the
migrant communities may also importantly affect the
long-term consequences of movement between locations
with different health determinants.12,14,15 Early studies
performed mainly in Great Britain and the Netherlands
revealed an increased risk of type 2 diabetes, hyperten-
sion16–18 obesity and metabolic syndrome in some ethnic
minority groups. Cultural reasons may obstacle the dis-
semination of prevention strategies among immigrants,
and communication between healthcare providers and
migrant clients remains poor. In the present European
economic context, the lack of implementation of specific
national migrant health prevention policies can thus
increase the burden of cardiovascular (myocardial infarc-
tion and stroke) and renal disease (dialysis) in the next
few decades.19
Migrants from low and middle-income countries (LMIC)
may also develop cardiovascular complications in the
medium to long term as a consequence of the natural
history of disease acquired in native countries and almost
forgotten in Europe. The issue is relevant for rheumatic
heart disease, which remains a major burden in different
areas of the world.20–22 To be effective in the long term,
the management of health issues resulting from popu-
lation mobility will require an integration of national and
global health initiatives.23 For medical knowledge to
improve health, health workers and patients need to hear
about it, and prevention strategies and relevant treatment
must be available and used appropriately. The aims of the
present collaborative multidisciplinary initiative report
are to collect information on different aspects of health
and migration to make the health services research com-
munity and policy-makers more aware of the potential
future consequent load for health systems, and to stress
the importance of improving data collection for migrant
health in Italy.
Health status of migrants and ethnic
populations
Hypertension and stroke
Consistently, high mortality and incidence stroke rates
have been observed for migrants of West African origin.
Age-standardized and sex-specific stroke mortality rates
for 1979–83, 1989–93 and 1999–2003 were higher for all
migrant groups in each time period. More precisely in
1999–2003, stroke mortality was almost 200% higher
among male migrants from West Africa, and almost
100% higher among those from the Caribbean.24 These
findings bear similarities with the high stroke mortality of
black Surinamese and Antillean-born residents in the
Netherlands, and the higher stroke mortality of black
people in the United States.25,26 This pattern has beenopyright © Italian Federation of Cardiology. Unaattributed to high rates of hypertension among people of
western African origin. There is consensus that among
people of African origin hypertension is three-fold to
four-fold more prevalent than in the European popu-
lation.16,18,27–32 This is true for men and women and is
present at any age, at least in adulthood. Finally, the
higher rates of hypertension in people from African
descent in Europe are confirmatory of the USA
African-American and white comparisons.17,33,34
It is uncertain whether this is mostly because of genetic or
environmental factors.35 A predominant role of the
environment is suggested by studies that found a higher
prevalence of hypertension of West African migrants
compared with people in their countries of origin.27 Body
weight and sodium intake increases were found to be the
main determinants of blood pressure (BP) increase in
subjects who migrated to Israel and Italy from Ethiopia36
and Somalia,37 respectively. More precisely, 30% of
normotensive peoplemigrated to Italy from Somalia were
hypertensive after a 6-month stay in Florence.37 In the
same subjects, a reduced sensitivity of the afferent
pathway of the cardiopulmonary reflex with resultant
defective inhibitory afference to the sympathetic outflow
was also shown.38 Sodium sensitivity and the reduced
response of the afferent pathway of the cardiopulmonary
reflex38 are in agreement with the better response of
hypertensive blacks to calcium blockers and diuretics
than to ACE inhibitors and b-adrenergic blockers.39
Further studies evaluating the efficacy of tailored dietary
and pharmacologic treatment in ethnic minorities living
in Europe are needed. The importance of genetic factors
associated with hypertension in African blacks is also
evident because differences in BP and hypertension
prevalence between ethnic groups are known to exist.40
Chinese-origin people have slightly higher BP and pre-
valence of hypertension than white individuals.41,42
Overall in South Asians, BP values were found to be
similar, but there is heterogeneity among subgroups
living in the same European country,17 and between
the same subgroups living in different European
countries.30,43 Increased stroke mortality levels in ethnic
minorities24 may also be partly linked to other factors,
such as problems in timely diagnosis and care for patients
with hypertension or stroke. Although the evidence on
this issue is still inconclusive, there are indications of
ethnic differences in the control and treatment of high
BP.16,30,43
Ischemic heart disease
Fischbacher et al.44 examined the incidence of fatal and
non-fatal myocardial infarction through a record-linked,
retrospective cohort study of 4.6 million people that
linked individual ethnic groups from the 2001 census
to Scottish hospital discharge and mortality data from
2001 to 2003. The incidence of acute myocardial infarc-
tion (fatal combined with non-fatal) was higher in Southuthorized reproduction of this article is prohibited.
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picture reported in women. Forouhi et al.45 found a higher
incidence of coronary death in South Asian men recruited
in west London compared with Europeanmen. Trends in
coronary heart disease (CHD) mortality in migrants to
England and Wales were recently investigated using
anonymized death records for 1979–83, 1989–93 and
1999–2003.24 In all three time periods, compared with
men born in England and Wales, men born in Jamaica,
other Caribbean countries, or West Africa had signifi-
cantly lower coronary mortality, whereas those born in
East Africa, India, Pakistan or Bangladesh had higher
mortality. Although there was a general pattern of decline
in age-standardized and sex-specific death rates between
1979 and 2003, the declines were smaller for many
migrant groups than for people born in England and
Wales.24 As a result, the groups with mortality higher
than people born in England and Wales remained con-
sistently so over the period. The disparity increased for
coronary mortality in men born in Pakistan and Bangla-
desh. Other English studies confirmed the high rates of
CHD mortality among residents born in the Indian sub-
continent.24,46 A striking feature of these trends is the
erosion of low coronary disease mortality in some groups.
Women from Jamaica and men from Hungary now have
coronary death rates higher than those born in England
and Wales. In all of these groups, modifiable risk factors
such as smoking, obesity and lack of sufficient physical
activity are related to cardiovascular risk.24 Likewise in
Sweden, the incidence of myocardial infarction was 50%
higher among men born in south Asia, being 20–30%
lower among men born in North Africa.47 Similar patterns
are observed in other European countries.48–51 The
causes of the higher CHD rates are still uncertain, and
may also be related to genetic factors. South Asian
migrants have greater CHD risk at similar levels of body
mass index.
Cultural difference in symptom presentation needs to be
recognized by clinicians if mortality rates in this high-risk
group are to be reduced. Over 18-year follow-up of
London healthy civil servants in the Whitehall II study,
South Asians had higher cumulative frequencies of
angina (17.0 vs. 11.3%, P< 0.001) compared with white
individuals.52 However, South Asians are less likely than
White British to present with classic symptoms of myo-
cardial infarction, and some argue that this makes diag-
nosis difficult and possibly delays essential treatment.
Bangladeshi patients with acute myocardial infarction
often present with atypical symptoms, which may lead
to slower triage in the casualty department and delay in
essential treatment.53 Design of health services must
indeed recognize differential presentation according to
ethnicity to improve access. This was highlighted by a
UK study using the Rose Angina questionnaire, which
has been extensively used in different cultural settings
and epidemiological studies of CHD. In this study,pyright © Italian Federation of Cardiology. UnauFischbacher et al.54 found that definite Rose angina
showed lower sensitivity for other measures in South
Asians than in Europeans: sensitivity for a doctor’s diag-
nosis was 21% in South Asian and 37% in European men.
Thus, the performance of the Rose angina questionnaire
was sufficiently inconsistent to warrant further work to
achieve greater cross-cultural validity.
The impact of differential access to healthcare on ethnic
differences in cardiovascular mortality is unclear. Current
recommendations for primary prevention of CVD in
high-risk subjects include the use of antiplatelet therapy
(aspirin), b-blockers, ACE inhibitors and statins. In gen-
eral, there are limited data in relation to different effec-
tiveness in the ethnicity, although there are some data in
relation to different usage of these drugs, or uptake of
prevention measures. For example, an audit of primary
care angina management in England55 reported smoking
cessation advice in 97.1% of white Europeans, compared
with 46.0% of non-white subjects. Beta-blocker use, as
well as weight and exercise advice, was less common
among non-white subjects. More data are available in the
non-UK setting. Brown et al.56 reported that African
Americans and Hispanics are less likely to take aspirin
than their white European counterparts, and this was not
accounted for by differences in sociodemographic charac-
teristics and CVD risk factors among ethnic minorities.
Diabetes and overweight
With few exceptions, diabetes mellitus incidence,57
prevalence58–60 and mortality rates25,61,62 are much
higher among migrants than among locally born resi-
dents. In the Netherlands, diabetes mellitus prevalence
rates were two times higher among migrants (i.e. those
born in Turkey, Morocco, Suriname or the Antilles) than
among the locally born population.63 Even larger differ-
ences were observed in terms of diabetes mellitus
mortality (i.e. deaths for which diabetes mellitus was
identified as the ‘underlying’ cause of death), with three
times higher rates among migrant men, and four times
higher rates among migrant women compared with the
locally born population. Migrants of Surinamese origin
had the highest prevalence and mortality rates.25
Although the higher CAD mortality rates in migrants
are closely linked to higher diabetes mellitus prevalence
rates,25 differences in case fatality might also play a role.
However, direct evidence on case fatality among
migrants in Europe is scarce. In an English follow-up
survey diabetic patients from South Asia had higher
diabetes mortality rates than European diabetic patients,
especially at younger ages.57 Using mortality data, a
European study reviewed the extent to which diabetes
mellitus mortality was more common among migrants.61
The study considered data on 30 migrant groups in seven
European countries. For the majority of migrant groups,
diabetes mellitus mortality was found to be much higher
than for locally born residents. On average, diabetesthorized reproduction of this article is prohibited.
CHealth of migrants: a missed opportunity? Modesti et al. 687mellitus mortality among migrants was 90% higher for
men and 120% higher for women. These findings illus-
trate that among non-communicable diseases with suffi-
cient data available, diabetes mellitus is the only disease
that is much more common in virtually all migrant
groups61 (Table 1).
According to the Health Survey for England,64 the preva-
lence of diabetes among migrants was more than five-fold
that of all women and increased by 16% (compared with
2% for all women) among women aged 55 years and older.
However, few national data source of risk factor
exposures for ethnic groups are available. Prevalence
of diabetes mellitus is closely linked to overweight and
obesity. The prevalence of overweight including obesity
in Bangladeshis, although lower than for the general
population, increased between 1999 and 2004 by 8%
for men and 14% for women (compared with 4% for all
men and 3% for all women), and the prevalence of
diabetes was highest in Bangladeshi men, four-fold that
of men in general, in both years. High prevalence of
diabetes and obesity were also observed in migrants from
the middle East area.65–68 A certain susceptibility to
insulin resistance and abdominal adiposity, the intrau-
terine environment and biological imprinting all act
synergistically to increase the risk of diabetes mellitus
in migrant populations.69 In addition to genetic predis-
position, there are several other interacting causes of the
increased diabetes mellitus risk of migrants, including
changing environments and insufficient medical con-
trol.70,71 Metabolic control is poor among migrant groups
with diabetes, and HbA1c (the amount of glucose that is
being carried by the red blood cells in the body) in
migrants is generally higher than in the locally born
population, increasing the risk of diabetic compli-
cations.72 A more general explanation suggests that
migrants’ excess diabetes mellitus mortality is due to a
dramatic change from a poor to an affluent environ-
ment.60 Lifestyle factors that are thought to be involved
include both physical inactivity and unhealthy diet.opyright © Italian Federation of Cardiology. Una
Table 1 MMRs by country-of-birth groups in Europe adjusted for
age and diabetes mortality level of countries of residence61
Regression model
Age and country-adjusted MRRsa
Men MRR (95% CI) Women MRR (95% CI)
All migrants 1.9 (1.8–2.0) 2.2 (2.1–2.3)
North Africanb 1.4 (1.3–1.4) 1.7 (1.5–1.8)
Turkish 1.7 (1.4–2.0) 2.1 (1.7–2.6)
South Asian 3.7 (3.4–4.0) 4.4 (4.0–4.9)
GDP of COB
1Q (<$2400) 3.8 (3.5–4.2) 3.9 (3.4–4.5)
2Q ($2400–$5300) 2.8 (2.6–2.9) 3.5 (3.2–3.7)
3Q ($5300–$9500) 1.8 (1.7–2.0) 2.2 (2.0–2.4)
4Q ($9500) 1.0 (0.9–1.2) 0.9 (0.8–1.1)
CI, confidence interval; COB, country of birth; GDP, gross domestic product; Q
(1Q–4Q), quartile (first–fourth quartile); MMR, mortality rate ratio. a Derived from
Poisson regression model with local-born populations as reference category.
b Refers to migrants originating either from Algeria, Egypt, Libya, Morocco, Sudan
or Tunisia.Their joint effect is to raise the prevalence of overweight
and obesity in many migrant populations as compared
with locally born residents.60,73 Obesity may be especially
important as a factor contributing to increased insulin
concentrations and decreased insulin sensitivity, under-
lining the need for migrant-sensitive health promotion
activities.74,75 However, higher rates of obesity and dia-
betes in ethnic minority groups in European countries are
not fully explained by traditional risk factors (obesity,
adiposity, diet and physical activity cannot explain this
risk of diabetes).76,77 A better understanding of why this
risk is increased is imperative in order to develop inter-
ventions and policies specifically in those populations.76
The high prevalence of diabetes mellitus amongmigrants
in Europe is also crucial for the design of screening
strategies. According to a survey conducted in Amster-
dam in 1999–2000,78 the high prevalence of diabetes
mellitus among Hindustani Surinamese (25.6%) and to a
lesser extent among African Surinamese (12.7%) (Dutch
6.8%) suggests that universal rather than selective screen-
ing may be indicated. If a choice for selective screening is
made however, an ethnicity-specific approach is required.
Renal disease
In the United Kingdom, the incidence of end-stage renal
failure among individuals from ethnic communities is
three to five times greater than among white Cauca-
sians.79,80 High incidence rates in age-specific ethnic
groups were observed for the whole of England (data
from 1991–1992),81 and for the Coventry population
(1992–1995 rates).82 The review of the London Thames
area population in the early 1990s83 also revealed that the
relative risk of renal replacement therapy (RRT) for
Asians compared with white patients aged 16–54 years
was 3.0, and rose with age to 8.0 for those aged over 65
years. A similarly alarming picture was seen nationwide.51
The high incidence rates in age-specific ethnic groups
observed in the years 1990–1995 were recently confirmed
for the years 1999–2004.84 There was a consistent
increase of 40% in all ethnic groups between the
1991 and 2001 cohorts (Fig. 2).84 The increase in patient
numbers was because of rising ethnic minority popu-
lations and increasing acceptance rates, especially in the
elderly. Higgins et al.82 did not observe difference in the
proportions of white Europeans and Indo-Asians receiv-
ing dialysis or placed on a waiting list for transplant
surgery. However, proportionately more Indo-Asian
patients, relative to white Europeans, started dialysis
and were waiting for kidney transplantation,85 and 33%
of Indo-Asians remained on the waiting list for more than
2 years without receiving a transplant, as compared with
19% of white Europeans (P< 0.025). The take-on rate is
likely to rise disproportionately as the migrant population
ages over the next 10 years.
Organ donation was lower in the Indo-Asian population
than in the white European population, with 40.1 kidneysuthorized reproduction of this article is prohibited.
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Annualized incidence rates for renal replacement therapy by age and
ethnicity (white, Indo-Asian, black) in the adult population of
Birmingham Health Authority in two 5-year periods (1990–1995 and
1999–2004) using the 1991 and 2001 UK population census
datasets and local programs data.84donated per million population per annum among white
Europeans, compared with 9.3 among Indo-Asians. Fac-
tors leading to a low rate of organ donation included age
distribution, the low number of Indo-Asians admitted to
intensive care and religious views about organ donation
from cadavers.
Knowledge of outcomes of RRT in ethnic minorities has
been very limited. A study of Indo-Asians from Bradford,
United Kingdom, raised the possibility of worse long-
term outcomes after renal transplantation in this group
compared with non-Asians, owing to a higher rate of
death with graft function.86
Patterns of renal disorder and the cause of renal failure are
different in Indo-Asians compared with Caucasians, with
higher rates of diabetic nephropathy, interstitial nephritis
and focal segmental glomerulosclerosis.80,87,88 Two
studies did suggest that idiopathic interstitial nephritis
as well as focal, segmental glomerulosclerosis, chronic
pyelonephritis and systemic lupus erythematous was
over-represented in this group.79,80 UK studies have
demonstrated a significant correlation between the inci-
dence/prevalence of RRT and social deprivation.89,90
Large studies in Australia, New Zealand and the United
States have also demonstrated this link.91,92 The effect of
deprivation is complicated by the association this has
with ethnicity. The UK Renal Registry published data in
2003 showing a clear association between deprivation and
ethnicity.93 Healthcare practitioners should also be aware
of the high prevalent use of alternative therapies and
should be proactive in obtaining this information from
patients.94
The issue of reducing the excess renal disease and renal
failure in ethnic communities needs to be addressed at
several levels.95 Interventions are classified as highlypyright © Italian Federation of Cardiology. Unaucost-effective (the cost of the intervention per disease
adjusted life-year saved is less than the gross domestic
product per person), cost-effective (one to three times the
gross domestic product per person) or not cost-effective
(more than three times the gross domestic product per
person). Screening for chronic kidney disease is cost-
effective in people with diabetes (selective screening),
whereas cost-effectiveness of screening for chronic
kidney disease in the general population is unclear.96 Data
are insufficient, however, to make generalizations especi-
ally to immigrants from LMIC. The integration of screen-
ing for chronic kidney disease with cardiovascular health
programs might indeed increase health awareness among
migrant communities.97–100 Several recent studies are
providing evidence that most forms of renal impairment
can be prevented or delayed.101,102 It is thus important to
ensure that best practice with respect to BP and diabetes
care is implemented for all patients.102,103
Issue for prevention
In spite of the unprecedented scientific advances in
biomedical research over the past several decades, many
under-served communities in the developed nations have
not benefited equally. A complex interaction of genetic,
biological, cultural and socioeconomic factors seems to be
responsible for a significant proportion of the health
disparities in many communities.104
A number of studies have revealed important barriers in
healthcare access.105,106 According to a recent retrospec-
tive analysis of administrative healthcare records in Italy,
all quality management indicators for diabetes, heart
failure, and ischemic heart disease were lower for citizens
from high-pressure migration countries than for citizens
from highly developed countries and Italians.107 Further-
more, people from high-pressure migration countries
were also more likely to contact emergency services
and less likely to visit specialist doctors or use preventive
care.107 Importantly, patients from highly developed
countries did not differ from Italians in their adherence
to disease management schemes. Generally, the impact
of the culture of origin diminishes with increasing length
of stay.108 Although the increased risk of developing
CHD declined somewhat in second-generation Finnish
immigrants in Sweden, the persisting risk suggests the
combination of environmental and genetic factors.108,109
Effective communication is essential in establishing a
diagnosis and treatment plan.110 Although it is well
recognized that our ability to provide optimal care impor-
tantly relies on our communication skills, cultural differ-
ences between the physician and the patient may create
communication barriers so significant that our patients
leave the office not knowing what we are telling them.
Culture has been defined as ‘beliefs and behaviors
that are learned and shared by members of a group’.111
Gestures are not universal; personal space, the space
between individuals during a one-on-one privatethorized reproduction of this article is prohibited.

















The Perceptions, Enablers, Nurturers (PEN-3) model.conversation, is much closer in many cultures (i.e. Latin
American or Middle Eastern); direct or prolonged eye
contact with the patient may be thought to signify dis-
respect causing unnecessary miscommunications.110 The
way a patient experiences his or her biomedical ailment is
also influenced by specific cultural norms, or personal
health belief systems. As a consequence, certain con-
ditions may be ‘acceptable’ or even desired. In low-
income countries, women have high odds of obesity
and abdominal obesity.98 The importance of culture is
evident because gender differences start at puberty.112
Abdominal obesity was found in nearly 80% of Iranian
women living both in Iran and in Sweden.32 Likewise in
the Netherlands, the prevalence of central obesity was
higher in women than in men, sex differences being
particularly larger in ethnic minority groups, especially
in African-Surinamese than in white Dutch.113 Given the
beneficial effects of physical activity on weight reduction,
promotion of physical activity may help to bridge the sex
gap in the metabolic syndrome, particularly in ethnic
minority women in whom obesity is highly prevalent, but
physical activity levels are low.113 Investment in women’s
education may present an important long-term invest-
ment in obesity prevention.114
Even while attempting to learn about specific cultural
norms, the dangers of stereotyping need to be acknowl-
edged, realizing that factors such as socioeconomic status,
educational level, occupation and family values and
belief systems may have as important a role in determin-
ing culture as does ethnicity.
The efficiency of prevention strategies implementation
among immigrant communities requires special consider-
ation of the importance of the social issue. By outlining an
approach that examines health beliefs, decisions and
behaviours within the context of culture, the Perceptions,
Enablers, Nurturers (PEN-3) model seeks to empower
communities through their intrinsic positive and unique
qualities so that culturally appropriate interventions can
be planned, implemented and evaluated.115–118 The
PEN-3 model consists of three interrelated domains:
cultural empowerment, relationships and expectations
and cultural identity. Each of the domains consists of
three components (Fig. 3). The first two domains, cross-
tabulated in a 3 3 table,115,119 serve as the assessment
tool kit to inform the intervention, whereas the last
domain, cultural identity, determines the point of entry
or entries for intervention (person, extended family and/
or neighbourhood, i.e. community including entities such
as the healthcare system), thereby increasing its effec-
tiveness. The intervention should thus not be focused
only on the individual but rather on the context and
community, otherwise change may not be sustainable.
Less is known about the enabling factors, whereas insight
into these is equally important in generating solutions to
enhance healthcare access, CVD prevention and BPopyright © Italian Federation of Cardiology. Unacontrol. In line with this, intervention efforts should be
sensitive to the sociocultural contexts of communities in
order to be effective. Television has the remarkable
potential to influence people’s behaviours and norms.
When used for good, television can sometimes have an
even bigger positive impact than a doctor’s advice. For
the migrant populations, such information might give
insights into how exposure to different environmental
situations might influence their health outcomes.
Conclusion
Changes in lifestyle and diet habits following urbaniz-
ation are greatly contributing to increase the prevalence
of hypertension, obesity, diabetes13,120–122 and kidney
damage123,124 in LMIC. The effects of these global
changes are now perceived also in Italy where although
information regarding cardiovascular risk in migrants is
scarce, the retrospective analysis of administrative
healthcare records has been indicating that diabetes
and hypertension are more prevalent among some ethnic
minority groups than European descents.107 The aging of
ethnic minority populations can lead to a future burden of
cardiovascular (myocardial infarction and stroke) and
renal disease (dialysis) in the next few decades, which
will increase local need for health services significantly.
Therefore, in Italy, much needs to be done especially in
the collection of sound data, which is the first step to
allow central governments identifying this issue as an
important public health concern. Specific measures to
control diabetes, hypertension and secondary compli-
cations in susceptible populations will contribute both
to safeguarding health and to economies in care spending.
Healthcare professionals have a crucial role to play here.
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